Expression of cyclooxygenase-2 in human gastric carcinoma

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1276-1280

  Ristimäki, Ari ^a,b   Honkanen, Niina ^a   Jänkälä, Heidi ^a   Sipponen, Pentti ^c   Härkönen, Matti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ANTIGEN EXPRESSION; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER SURVIVAL; CELL PROTECTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0141854494     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Coleman, M. P., Esteve, J., Damiecki, P., Arslan, A., and Renard, H. Trends in cancer incidence and mortality. IARC Scientific Publications No. 121, pp. 193-224. Lyon, France: IARC, 1993.
2. Cancer Incidence in Finland 1994. Finnish Cancer Registry, Helsinki, 1996.
3. Wanebo, H. J., Kennedy, B. J., Chmiel, J., Steele, G. J., Winchester, D., and Osteen, R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann. Surg., 218: 583-592, 1993.
4. Laurén, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinomas: an attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
5. Antonioli, D. A. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer Hum. Pathol., 25: 994-1005, 1994.
6. Stemmermann, G., Heffelfinger, S. C., Noffsinger, A., Hui, Y. Z., Miller, M. A., and Fenoglio-Preiser, C. M. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum. Pathol., 25: 968-981, 1994.
7. Tahara, E., Semba, S., and Tahara, H. Molecular biological observations in gastric cancer. Semin. Oncol., 23: 307-315, 1996.
8. Steele, V. E., Moon, R. C., Lubet, R. A., Grubbs, C. J., Reddy, B. S,. Wargovich, M., McCormick, D. L., Pereira, M. A., Crowell, J. A., Bagheri, D., Sigman, C. C., Boone, C. W., and Kelloff, G. J. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J. Cell. Biochem. Suppl. 20: 32-54, 1994.
9. Giardiello, F. M., Offerhaus, G. J. A., and DuBois, R. N. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A: 1071-1076, 1995.
10. Isomäki, H. A., Hakulinen, T., and Joutsenlahti, U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J. Chronic Dis., 31: 691-696, 1978.
11. Laakso, M., Mutru, O., Isomäki, H., and Koota, K. Cancer mortality in patients with rheumatoid arthritis. J. Rheumatol., 13: 522-526, 1986.
12. Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H-O., Hacker, D. G., Hoover, R., and Fraumeni, J. F., Jr. Incidence of cancer among patients with rheumatoid arthritis. J. Natl. Cancer Inst., 55: 307-311, 1993.
13. Giardiello, F. M. Sulindac and polyp regression. Cancer Metastasis Rev., 13: 279-283, 1994.
14. Thun, M. J. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev., 13: 269-277, 1994.
15. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
16. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath C. W., Jr. Aspirin use and risk of fatal cancer. Cancer Res., 53: 1322-1327, 1993.
17. Eberhart, C. E., and Dubois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
18. Smith, W. L., and DeWitt, D. L. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin. Nephrol., 15: 179-194, 1995.
19. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
20. Smith, W. L., Garavito, R. M., and DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem., 271: 33157-33160, 1996.
21. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: Why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
22. 716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell, 87: 803-809, 1996.
23. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
24. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K., and Sugimura, T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J. Cancer Res. Clin. Oncol., 122: 219-222, 1996.
25. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
26. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
27. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardieilo, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
28. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
29. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and-2 in human colorectal cancer. Cancer. Res., 55: 3785-3789, 1995.
30. Gustafson-Svärd, C., Lilja, I., Hallböök, O., and Sjödahl, R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut, 38: 79-84, 1996.
31. Kutchera, W., Jones, D. A., Matsunami, N., Grodens, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
32. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guadinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
33. Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T., Hla, T. Induction of cyclooxygenase-2 by interleukin-1α. Evidence for post-transcriptional regulation. J. Biol. Chem., 269: 11769-11775, 1994.
34. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and Dubois, R. N. Elevated cyclooxygenase-2 levels in min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
35. O'Neill, G. P., and Ford-Hutchinson, A. W. Expression of mRNA for cyclooxy-genase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330: 156-160, 1993.
36. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., and O'Neill, G. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111: 445-454, 1996.
37. Scholz, K., Furstenberger, G., Müller-Deccer, K., and Marks, F. Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J., 309: 263-269, 1995.
38. 2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum. Cancer Res., 50: 381-384, 1990.
39. Tsuji, S., Kawano, S., Sawaoka, H., Takei, Y., Kobayashi, I., Nagano, K., Fusamoto, H., and Kamada, T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot. Essent. Fatty Acids, 55: 179-183, 1996.
40. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
41. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science (Washington DC), 265: 956-959, 1994.
42. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56: 4424-4429, 1996.
43. Srivastava, S. K., Tetsuka, T., Daphna-Iken, D., and Morrison, A. R. IL-1β stabilizes COX II mRNA in renal mesangial cells: role of 3′-untranslated region. Am. J. Physiol., 267: F504-F508, 1994.
44. Ristimäki, A., Narko, K., and Hla, T. Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J., 318: 3253-3231, 1996.
45. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
46. Hla, T., Ristimäki, A., Appleby, S., and Barriocanal, J. Cyclooxygenase gene expression in inflammation and angiogesis. Ann. NY Acad. Sci., 696: 197-204, 1993.
47. Müller-Deccer, K., Scholz, K., Marks, F., and Furstenberger, G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinog., 12: 31-41, 1995.
48. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
49. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by prostaglandin-independent pathway. Biochem. Phamacol., 52: 237-245, 1996.
50. Fujiwara, Y., Tarnawski, A., Fujiwara, K., Arakawa, T., and Kobayashi, K. Inhibitory effects of indomethacin on growth and proliferation of gastric carcinoma cells KATO III. J. Physiol. Pharmacol., 44: 147-154, 1993.
51. Ballif, B. A., Mincek, N. V., Barratt, J. T., Wilson, M. L., and Simmons, D. L. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein. Proc. Natl. Acad. Sci. USA, 93: 5544-5549, 1996.